{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:19:43Z","timestamp":1787840383945,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>We wanted to present a rare case of metastatic grade 2 spinal ependymoma with an atypical course at the time of diagnosis. Temozolomide plus capecitabine chemotherapy was started in May 2018 on a 30-year-old female patient with sacral ependymoma who had extensive lung metastases at the time of diagnosis. The patient remained in remission for approximately 29 months, and the current chemotherapy was continued until it progressed in November 2020. According to this case report, a combination of temozolomide and capecitabine may be the best treatment option for ependymoma patients.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_1664_22","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:02:15Z","timestamp":1728295335000},"page":"1625-1627","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Extensive metastatic ependymoma with long-term progression-free survival with capecitabine plus temozolomide combination chemotherapy: A case report"],"prefix":"10.4103","volume":"20","author":[{"given":"Engin","family":"Hendem","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Korkmaz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Araz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek K.","family":"Ery\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"\u00c7a\u011flayan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda T.","family":"Ay\u00e7i\u00e7ek","sequence":"additional","affiliation":[{"name":"Department of Pathology, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu\u011fra","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Arta\u00e7","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"R1-20241226","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0360-3016(93)90231-J","article-title":"Spinal cord ependymomas:A retrospective analysis of 59 cases","volume":"27","author":"Waldron","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-20241226","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00177617","article-title":"Extraneural metastases in ependymoma","volume":"14","author":"Newton","year":"1992","journal-title":"J Neurooncol"},{"key":"R3-20241226","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system:A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"R4-20241226","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3171\/jns.1990.72.4.0523","article-title":"Intramedullary ependymoma of the spinal cord","volume":"72","author":"McCormick","year":"1990","journal-title":"J Neurosurg"},{"key":"R5-20241226","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2005.09.038","article-title":"Spinal cord gliomas:A multi-institutional retrospective analysis","volume":"64","author":"Abdel-Wahab","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-20241226","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/neuonc\/not038","article-title":"Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma:A retrospective multicenter study by the Korea Spinal Oncology Research Group","volume":"15","author":"Lee","year":"2013","journal-title":"Neuro Oncol"},{"key":"R7-20241226","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/neuonc\/noaa240","article-title":"A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma","volume":"23","author":"Gilbert","year":"2021","journal-title":"Neuro Oncol"},{"key":"R8-20241226","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12885-016-2323-0","article-title":"Chemotherapy for intracranial ependymoma in adults","volume":"16","author":"Gramatzki","year":"2016","journal-title":"BMC Cancer"},{"key":"R9-20241226","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1212\/WNL.0b013e3181c1df34","article-title":"Bevacizumab for recurrent ependymoma","volume":"73","author":"Green","year":"2009","journal-title":"Neurology"},{"key":"R10-20241226","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jocn.2014.09.006","article-title":"Supratentorial extraventricular anaplastic ependymoma with extracranial metastasis","volume":"22","author":"Pachella","year":"2015","journal-title":"J Clin Neurosci"},{"key":"R11-20241226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11060-016-2135-8","article-title":"Spinal cord ependymoma:A review of the literature and case series of ten patients","volume":"128","author":"Celano","year":"2016","journal-title":"J Neurooncol"},{"key":"R12-20241226","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0022-3468(99)90020-9","article-title":"Sacrococcygeal ependymoma:Case report and review of the literature","volume":"34","author":"Johnson","year":"1999","journal-title":"J Pediatr Surg"},{"key":"R13-20241226","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1227\/NEU.0b013e3182004c1e","article-title":"Surgery for spinal cord ependymomas:Outcome and prognostic factors","volume":"68","author":"Bostr\u00f6m","year":"2011","journal-title":"Neurosurgery"},{"key":"R14-20241226","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-0032-1329888","article-title":"Extraneural metastasis of ependymoma in the cauda equina","volume":"3","author":"Fujimori","year":"2013","journal-title":"Global Spine J"},{"key":"R15-20241226","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/paor.1999.0056","article-title":"Extraneural metastasizing ependymoma of the spinal cord","volume":"5","author":"Graf","year":"1999","journal-title":"Pathol Oncol Res"},{"key":"R16-20241226","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3171\/jns.1977.47.5.0771","article-title":"A metastasizing ependymoma of the cauda equina. Case report","volume":"47","author":"Mavroudis","year":"1977","journal-title":"J Neurosurg"},{"key":"R17-20241226","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/neuonc\/nov167","article-title":"Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult:A retrospective study","volume":"18","author":"Rud\u00e0","year":"2016","journal-title":"Neuro Oncol"},{"key":"R18-20241226","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/neuonc\/nov181","article-title":"Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma","volume":"17","author":"Wright","year":"2015","journal-title":"Neuro Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1664_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:21:48Z","timestamp":1787836908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1664_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1664_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"assertion":[{"value":"2022-08-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}